MagnetisMM-32

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Arms / Cohorts

Experimental:Experimental Group : Elranatamab

Accepting patients

Comparator Group:Comparator Group: Carfilzomib and Dexamethasone

Accepting patients

Active Comparator:Comparator Group: Elotuzumab, Pomalidomide and Dexamethasone

Accepting patients

Comparator Group:Comparator Group: Pomalidomide, Bortezomib and Dexamethasone

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.